Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

93 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
A CD44high/EGFRlow subpopulation within head and neck cancer cell lines shows an epithelial-mesenchymal transition phenotype and resistance to treatment.
La Fleur L, Johansson AC, Roberg K. La Fleur L, et al. Among authors: roberg k. PLoS One. 2012;7(9):e44071. doi: 10.1371/journal.pone.0044071. Epub 2012 Sep 25. PLoS One. 2012. PMID: 23049743 Free PMC article.
Effects of cytokines on matrix metalloproteinase expression in oral squamous cell carcinoma in vitro.
Sundelin K, Roberg K, Grénman R, Håkansson L. Sundelin K, et al. Among authors: roberg k. Acta Otolaryngol. 2005 Jul;125(7):765-73. doi: 10.1080/00016480510027484. Acta Otolaryngol. 2005. PMID: 16012040
Role of lysosomal cathepsins in naphthazarin- and Fas-induced apoptosis in oral squamous cell carcinoma cells.
Johansson AC, Norberg-Spaak L, Roberg K. Johansson AC, et al. Among authors: roberg k. Acta Otolaryngol. 2006 Jan;126(1):70-81. doi: 10.1080/00016480510043422. Acta Otolaryngol. 2006. PMID: 16308258
Radiotherapy response in oral squamous carcinoma cell lines: evaluation of apoptotic proteins as prognostic factors.
Roberg K, Jonsson AC, Grénman R, Norberg-Spaak L. Roberg K, et al. Head Neck. 2007 Apr;29(4):325-34. doi: 10.1002/hed.20520. Head Neck. 2007. PMID: 17163470
Effects of cisplatin, alpha-interferon, and 13-cis retinoic acid on the expression of Fas (CD95), intercellular adhesion molecule-1 (ICAM-1), and epidermal growth factor receptor (EGFR) in oral cancer cell lines.
Sundelin K, Roberg K, Grénman R, Håkansson L. Sundelin K, et al. Among authors: roberg k. J Oral Pathol Med. 2007 Mar;36(3):177-83. doi: 10.1111/j.1600-0714.2006.00503.x. J Oral Pathol Med. 2007. PMID: 17305640
Multiple genotypic aberrances associate to terminal differentiation-deficiency of an oral squamous cell carcinoma in serum-free culture.
Roberg K, Ceder R, Farnebo L, Norberg-Spaak L, Grafström RC. Roberg K, et al. Differentiation. 2008 Oct;76(8):868-80. doi: 10.1111/j.1432-0436.2008.00267.x. Epub 2008 Apr 29. Differentiation. 2008. PMID: 18452551
Polymorphism of FGFR4 in cancer development and sensitivity to cisplatin and radiation in head and neck cancer.
Ansell A, Farnebo L, Grénman R, Roberg K, Thunell LK. Ansell A, et al. Among authors: roberg k. Oral Oncol. 2009 Jan;45(1):23-9. doi: 10.1016/j.oraloncology.2008.03.007. Epub 2008 May 19. Oral Oncol. 2009. PMID: 18487077
Number of negative points: a novel method for predicting radiosensitivity in head and neck tumor cell lines.
Farnebo L, Jerhammar F, Vainikka L, Grénman R, Norberg-Spaak L, Roberg K. Farnebo L, et al. Among authors: roberg k. Oncol Rep. 2008 Aug;20(2):453-61. Oncol Rep. 2008. PMID: 18636211
Matrix metalloproteinase-7 and -13 expression associate to cisplatin resistance in head and neck cancer cell lines.
Ansell A, Jerhammar F, Ceder R, Grafström R, Grénman R, Roberg K. Ansell A, et al. Among authors: roberg k. Oral Oncol. 2009 Oct;45(10):866-71. doi: 10.1016/j.oraloncology.2009.02.008. Epub 2009 May 12. Oral Oncol. 2009. PMID: 19442568
Proteins and single nucleotide polymorphisms involved in apoptosis, growth control, and DNA repair predict cisplatin sensitivity in head and neck cancer cell lines.
Farnebo L, Jedlinski A, Ansell A, Vainikka L, Thunell LK, Grénman R, Johansson AC, Roberg K. Farnebo L, et al. Among authors: roberg k. Int J Mol Med. 2009 Oct;24(4):549-56. doi: 10.3892/ijmm_00000264. Int J Mol Med. 2009. PMID: 19724896
93 results
Jump to page
Feedback